Revascularization treatment recommendations based on atherosclerotic disease distribution: Coronary artery bypass grafting versus stenting

Current Atherosclerosis Reports

Volumn 10, Issue 5, 2008, Pages 434-437

  de la Cruz, Kim I ^b   Tsai, Peter I ^b   Cohn, William E ^b   Cooley, Denton A ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; STABLE ANGINA PECTORIS; TREATMENT INDICATION; ANGINA PECTORIS; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHY; DRUG ELUTING STENT; HEART INFARCTION; MORTALITY; PATHOLOGY; REOPERATION; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; REOPERATION; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 55449124549     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-008-0066-3     Document Type: Article

References (20)

1. Boden WE, O'Rourke RA, Teo KK, et al.: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
2. Eagle KA, Guyton RA, Davidoff R, et al.: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004, 110:e340.
3. Gupta A, Burke J, Bove A: CoronPry arterial revascularization: past, present, future: Part I - historical trials. Clin Cardiol 2006, 29:290-294.
4. Nordmann AJ, Briel M, Bucher HC: Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: A meta-analysis. Eur Heart J 2006, 27:2784-2814.
5. Lagerqvist B, James SK, Stenestrand U, et al.: Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007, 356:1009-1019.
6. Guyton RA: Coronary artery bypass is superior to drugeluting stents in multivessel coronary artery disease. Ann Thorac Surg 2006, 81:1949-1957.
7. Brown ML, Sundt TM III, Gersh BJ: Indications for revascularization. In Cardiac Surgery in the Adult, edn 3. Edited by Cohn LH. New York: McGraw-Hill Education; 2007:551-572.
8. CASS Principal Investigators: CoAonary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass graft surgery: Survival data. Circulation 1983, 68:939-950.
9. The Veterans Administration Coronary Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984, 311:1333-1339.
10. Varnauskas E; European Coronary Surgery Study Group: Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988, 319:332.
11. Hueb W, Soares PR, Gersh BJ, et al.: The Medicine, Angioplasty or Surgery Study (MASS-II): A randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one year results. J Am Coll Cardiol 2004, 43:1743-1751.
12. Hannan EL, Wu C, Walford G, et al.: Drug eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008, 358:331-341.
13. Hannan EL, Racz MJ, Walford G, et al.: Long-term outcomes of coronary artery bypass grafting versus stent implantation. N Engl J Med 2005, 352:2174-2183.
14. Serruys PW, Ong AT, Morice MC, et al.: Five-year outcomes after coronary artery stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005, 46:575-581.
15. Rodriguez A, Bernardi V, Navia J, et al.: Argentine randomized study. Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI-II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001, 37:51-58.
16. Rodriguez AE, Baldi J, Pereira CF, et al.: Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI-II). J Am Coll Cardiol 2005, 46:582-588.
17. Stone GW, Ellis SG, Cannon L, et al.; TAXUS V ISR Investigators: Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005, 294:1215-1223.
18. Stone GW, Midei M, Newman W, et al.; SPIRIT III Investigators: Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008, 299:1903-1913.
19. Kar B, Adkins LE, Civitello AB, et al.: Clinical experience with the tandemheart percutaneous ventricular assist device. Texas Heart Inst J 2006, 33:111-115.
20. Tatoulis J, Buxton BF, Fuller JA: Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004, 77:93-101.